Abstract
Despite the widespread need to assess cell-based viral infectivity during vaccine development and production, as well as viral clearance monitoring and adventitious agent testing for viral safety, traditional methods, including the end-point dilution assay (TCID50) and viral plaque assay, are slow, labor-intensive, and can vary depending upon the skill and experience of the user. LumaCyte’s Radiance® instrument uses Laser Force CytologyTM (LFC), a combination of advanced optics and microfluidics, to rapidly analyze the viral infectivity of cell populations in a quantitative fashion. LFC applies optical and fluidic forces to single cells in order to measure their intrinsic biophysical and biochemical properties without the use of stains, antibodies or fluorescent labels. These properties, including refractive index, change with a wide variety of biological phenomena, including viral infection, cell differentiation, activation, size, and cytoskeletal stiffness. Here, we present the experimental design and methods to use LFC data to facilitate rapid and robust infectivity measurements for a variety of applications including initial titer measurement (TCID50 replacement), in-process infectivity (e.g., bioreactor monitoring), and viral neutralization (PRNT replacement).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
World Health Organization (1997) Manual of laboratory methods for testing of vaccines used in the WHO Expanded Programme on Immunization
Guidance for Industry (2010) Characterization and qualification of cell substrates and other biological materials used in the production of viral vaccines for infectious disease indications. U.S.D.o.H.a.H. Services, editor. Office of Communication, Outreach and Development (OCOD) (HFM-40)
Gombold J et al (2014) Systematic evaluation of in vitro and in vivo adventitious virus assays for the detection of viral contamination of cell banks and biological products. Vaccine 32(24):2916–2926
Gates IV et al (2009) Quantitative measurement of varicella-zoster virus infection by semiautomated flow cytometry. Appl Environ Microbiol 75(7):2027–2036
Donis RO et al (2014) Performance characteristics of qualified cell lines for isolation and propagation of influenza viruses for vaccine manufacturing. Vaccine 32(48):6583–6590
Shurtleff AC et al (2012) Standardization of the filovirus plaque assay for use in preclinical studies. Viruses 4(12):3511–3530
Chou SW, Scott KM (1988) Rapid quantitation of cytomegalovirus and assay of neutralizing antibody by using monoclonal antibody to the major immediate-early viral protein. J Clin Microbiol 26(3):504–507
Thomas JA et al (2016) Development and application of a simple plaque assay for the human malaria parasite Plasmodium falciparum. PLoS One 11(6):e0157873
Heppner DG Jr et al (2017) Safety and immunogenicity of the rVSVG-ZEBOV-GP Ebola virus vaccine candidate in healthy adults: a phase 1b randomised, multicentre, double-blind, placebo-controlled, dose-response study. Lancet Infect Dis 17(8):854–866
Salje H et al (2014) Variability in dengue titer estimates from plaque reduction neutralization tests poses a challenge to epidemiological studies and vaccine development. PLoS Negl Trop Dis 8(6):e2952
Hebert CG et al (2018) Rapid quantification of vesicular stomatitis virus in Vero cells using Laser Force Cytology. Vaccine 36(41):6061–6069
Hebert CG, Hart SJ, Terray A (2014) Label free detection of pseudorabies virus infection in Vero cells using laser force analysis. Analyst 139(6):1472–1481
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Hebert, C.G., Rodrigues, K.L., DiNardo, N., Hachmann, AB. (2021). Viral Infectivity Quantification and Neutralization Assays Using Laser Force Cytology. In: Pfeifer, B.A., Hill, A. (eds) Vaccine Delivery Technology. Methods in Molecular Biology, vol 2183. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-0795-4_34
Download citation
DOI: https://doi.org/10.1007/978-1-0716-0795-4_34
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-0794-7
Online ISBN: 978-1-0716-0795-4
eBook Packages: Springer Protocols